Veterinary Medicines

PYROCAM 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES

Authorised
  • Meloxicam
Download as PDF

Product identification

Medicine name:
PYROCAM 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES
Pyrocam 20 mg/ml oplossing voor injectie voor runderen, varkens en paarden
Pyrocam 20 mg/ml solution injectable pour bovins, porcins et chevaux
Pyrocam 20 mg/ml Injektionslösung für Rinder, Schweine und Pferde
Active substance:
  • Meloxicam
Target species:
  • Pig
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Meloxicam
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        5
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        5
        day
    • Horse
      • Meat and offal
        5
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box with 1 colourless glass injection vial type I containing 20 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
  • Cardboard box with 1 colourless glass injection vial type I containing 50 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
  • Cardboard box with 1 colourless glass injection vial type I containing 100 ml and closed with a bromobutyl rubber stopper and sealed with an aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V663101
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0471/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/09/2024
Download
French (PDF)
Published on: 17/09/2024
Download
German (PDF)
Published on: 17/09/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/09/2024
Download
French (PDF)
Published on: 17/09/2024
Download
German (PDF)
Published on: 17/09/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/09/2024
Download
French (PDF)
Published on: 17/09/2024
Download
German (PDF)
Published on: 17/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."